Adaptive Alpha Opportunities ETF Price & Performance (AGOX)

Tema ETF Trust has introduced a novel approach by using historical average weightings of the S&P 500 constituents to structure its portfolio. This method assigns weights based on historical data since 1989, aiming to reflect long-term trends. The fund will rebalance quarterly, aligning with changes in the S&P 500.1

Adaptive Biotechnologies received a Buy rating from Goldman Sachs, citing strong prospects in minimal residual disease monitoring. Analysts highlight the company's strategic focus on hematologic cancers and its efforts to limit cash burn in its Immune Medicine business. The stock now has an expected upside of over 20%.23

The KFA Mount Lucas Managed Futures Strategy ETF has showcased impressive performance, with a standout 44.75% return during a challenging market period. Its negative correlation with the S&P 500 highlights its potential as a diversification tool for investors seeking alternative strategies.4